BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Autoimmunity
,
Cisplatin
,
rs7903146
,
BRCA1
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antigens CD19
Summary
General Info
Curated Studies
Most Correlated Studies
Dendritic cells treated with CD40L after treatment with TSLP or lipopolysaccharide
Memory B cells sorted for FCRL4+/- cell fractions after activation with sCD40L or CpG ODN 2006
Tonsil centroblast cells CD19+ CD38hi CD10+ IgD- CXCR4+ stimulated with CD40L and IL21
B-cells from peripheral blood of donors treated with CD40L
B cells activated by LPS and /or anti-CD40
Explore Curated Studies Results
Literature
Most Relevant Literature
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro.
Long-term safety and activity of humanized CD19 chimeric antigen receptor T cells for children and y…
18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell ther…
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy.
CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relaps…
CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatme…
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T C…
Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Y…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ